Logo
x

Search

Subscribe Now

submission

Janssen Report Submission of sBLA to the US FDA for the Approval of Stelara (ustekinumab) to Treat Juvenile Psoriatic Arthritis

Janssen Report Submission of sBLA to the US FDA for the Approval of Stelara (ustekinumab) to Treat Juvenile Psoriatic Arthritis

  • October 11, 2021
GSK and VIR Report EUA Submission to the US FDA for VIR-7831 to Treat COVID-19

GSK and VIR Report EUA Submission to the US FDA for VIR-7831 to Treat COVID-19

  • March 29, 2021
Astellas Reports NDA Submission of Enfortumab Vedotin to the MHLW for Locally Advanced or Metastatic Urothelial Cancer in Japan

Astellas Reports NDA Submission of Enfortumab Vedotin to the MHLW for Locally Advanced or Metastatic Urothelial Cancer in Japan

  • March 12, 2021
Takeda Reports NDA Submission of Lanadelumab to the MHLW as a Preventive Treatment for Hereditary Angioedema Attack in Japan

Takeda Reports NDA Submission of Lanadelumab to the MHLW as a Preventive Treatment for Hereditary Angioedema Attack in Japan

  • March 12, 2021
Takeda Reports NDA Submission to Import and Distribute Moderna's mRNA-1273 in Japan

Takeda Reports NDA Submission to Import and Distribute Moderna's mRNA-1273 in Japan

  • March 5, 2021
Amgen Reports sNDA Submission of Otezla (apremilast) to The US FDA's for Adults with Mild to Moderate Plaque Psoriasis

Amgen Reports sNDA Submission of Otezla (apremilast) to The US FDA's for Adults with Mild to Moderate Plaque Psoriasis

  • February 23, 2021
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.